Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07020520 · ClinicalTrials.gov registry record · NA
EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures
A NA study of Ureteral Stricture, sponsored by Urotronic.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 7
- Study locations
NCT07020520: Recruiting NA study of Ureteral Stricture, sponsored by Urotronic.
NCT07020520 is a NA study of Ureteral Stricture that is actively recruiting participants, run by Urotronic. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07020520, a NA study of Ureteral Stricture, is actively recruiting participants, sponsored by Urotronic.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 7
- Study locations
Study Summary
The main objective of this clinical investigation is to assess the safety and feasibility of the Optilume DCB for treatment of ureteric strictures.
Primary Outcome
Rate of successful treatment defined as meeting all the following criteria: * Technical success * Freedom from retreatment of target stricture through six months post stent removal * Renogram at 6 months showing stability or improvement in split function for impacted kidney defined as split function within 10% of baseline value or improved from baseline. * T1/2 stability or improvement from baseline to 6 months for impacted kidney
Conditions Studied
Interventions
- DEVICE Optilume
Study Locations (7)
New York
- Mount Sinai - New York
- NYU Langone - New York
California
- University of California Irvine - Orange
Florida
- Orlando Health - Orlando
Indiana
- Indiana University - Indianapolis
Texas
- University of Texas Southwestern - Dallas
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2031-07-30 |
| Phase | NA |
What NCT07020520 shows while recruiting
NCT07020520 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Ureteral Stricture appearing as the primary indexed condition, and to 1 intervention - of which Optilume is the first listed.
NCT07020520 lists 7 locations in 6 states (New York, California, Florida).
Frequently Asked Questions
What is clinical trial NCT07020520 about?
NCT07020520 is a clinical study titled "EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures". The main objective of this clinical investigation is to assess the safety and feasibility of the Optilume DCB for treatment of ureteric strictures.
What is the current status of trial NCT07020520?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-10-01. Estimated completion is 2031-07-30.
What conditions does trial NCT07020520 study?
This clinical trial studies the following conditions: Ureteral Stricture.
What interventions are being tested in trial NCT07020520?
The interventions under investigation include: Optilume (DEVICE).
Who is sponsoring clinical trial NCT07020520?
This trial is sponsored by Urotronic, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07020520 being conducted?
This trial has 7 study locations across California, Florida, Indiana, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ureteral Stricture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07020520's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI